Spinal Nucleus of Trigeminus
Introduction <table class="infobox infobox-cell">Category </td>Location </td>Cell Type </td>Neurotransmitter </td>Function </td>
Spinal Nucleus Of Trigeminus is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
Spinal Nucleus of Trigeminus
Introduction <table class="infobox infobox-cell">Category </td>Location </td>Cell Type </td>Neurotransmitter </td>Function </td>
Spinal Nucleus Of Trigeminus is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The spinal nucleus of the trigeminal nerve (Sp5) is a brainstem sensory nucleus that processes orofacial pain, temperature, and touch sensation. It receives primary afferent input from the [trigeminal nerve](/brain-regions/trigeminal-nerve) (cranial nerve V) and plays a critical role in craniofacial pain perception, including migraine and trigeminal neuralgia. [@paxinos2004]
Overview
Multi-Taxonomy Classification
Taxonomy Database Cross-References
External Database Links
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[Cell Ontology](https://www.ebi.ac.uk/ols4/ontologies/cl/)
[Human Cell Atlas](https://www.humancellatlas.org/)
[CellxGene Census](https://cellxgene.cziscience.com/)
[PanglaoDB](https://panglaodb.se/)
Subnuclear Organization The spinal nucleus of the trigeminal nerve is divided into three subnuclei:
Subnucleus Oralis (Sp5O) -传递触觉和本体感觉
Receives input from mechanoreceptors
Involved in discriminatory touch
Located rostrally in the nucleus
Subnucleus Interpolaris (Sp5I)
Intermediate processing
Both pain and touch integration
Visceral sensory information
Location between oralis and caudalis
Subnucleus Caudalis (Sp5C)
Pain and temperature processing
Most studied subnucleus
Laminal organization (laminae I-VI)
Critical for nociception
Comparable to spinal cord dorsal horn
Primary Trigeminal Afferents The Sp5 receives direct input from:
[Trigeminal ganglion](/cell-types/trigeminal-ganglion-neurons) neurons
Mechanoreceptors: facial touch, pressure
Nociceptors: pain, temperature
Proprioceptors: jaw position
Central Connections
[Trigeminal mesencephalic nucleus](/cell-types/mesencephalic-trigeminal-nucleus): proprioception
[Thalamus](/brain-regions/thalamus): ventral posteromedial nucleus (VPM)
[Cortex](/brain-regions/cortex): primary somatosensory area
[Brainstem reticular formation](/brain-regions/brainstem-reticular-formation): arousal
[Raphe nuclei](/brain-regions/raphe-nuclei): serotonin modulation
[Locus coeruleus](/brain-regions/locus-coeruleus): noradrenergic modulation
Periaqueductal gray: endogenous analgesia
Efferent Projections
Ascending Pathways
Trigeminothalamic tract : To VPM thalamusReticular formation : Brainstem arousalColliculus : Orienting responsesHypothalamus : Autonomic integrationLocal Circuits
Interneurons for processing
Recurrent inhibition
Feedforward excitation
Cross-modal integration
Pain Processing Mechanisms
Nociceptive Transmission Pain signals are transmitted through:
Primary afferent activation
Glutamate release (AMPA/Kainate receptors)
[NMDA receptor](/entities/nmda-receptor) activation (central sensitization)
Substance P and CGRP release
Ascending projection to thalamus
Central Sensitization The Sp5 is a site of central sensitization:
Wind-up phenomenon
Expansion of receptive fields
Hyperexcitability
Chronic pain states
Research by [Dubner and Ren (1997)](https://doi.org/10.1016/S0304-3959(97)00100-3) established the role of Sp5 in central sensitization.
Pain Modulation Endogenous pain modulatory systems:
Periaqueductal gray (PAG) : Activates descending inhibitionRostral ventromedial medulla (RVM) : Modulates pain transmissionEndogenous opioids : Enkephalins, endorphinsSerotonin and norepinephrine : Descending facilitation/inhibitionClinical Significance
Trigeminal Neuralgia [Trigeminal neuralgia](/diseases/trigeminal-neuralgia) (tic douloureux):
Severe episodic facial pain
Triggered by light touch
Usually involves V2/V3 divisions
Often due to vascular compression
Sp5 hyperexcitability
Migraine [Migraine](/diseases/migraine) involves Sp5:
Trigeminovascular system activation
Meningeal nociceptor stimulation
Central sensitization
Allodynia during attacks
Brainstem aura triggers
Temporomandibular Disorder [Temporomandibular disorder](/diseases/temporomandibular-disorder) (TMD):
Myofascial pain involvement
Sp5 central sensitization
Referred pain patterns
Comorbid with migraine
Atypical Facial Pain
Chronic facial pain syndromes
Sp5 dysfunction
Central sensitization
Difficult to treat
Multiple Sclerosis
Demyelination in Sp5
Facial numbness/pain
Sensory deficits
Treatment challenging
Neuroimaging Findings
MRI Studies
Increased Sp5 activity during migraine
Structural changes in chronic pain
Functional connectivity alterations
Diffusion tensor imaging abnormalities
PET Studies
Metabolic changes in Sp5
Treatment response monitoring
Biomarker development
Treatment Approaches
Pharmacological
Carbamazepine : First-line for trigeminal neuralgiaOxcarbazepine : Similar efficacyGabapentin : Neuropathic painBotulinum toxin : Injection for migraineTriptans : Acute migraine treatmentSurgical
Microvascular decompression
Radiofrequency rhizotomy
Glycerol rhizolysis
Gamma knife radiosurgery
Deep brain stimulation
Neuromodulation
Transcranial magnetic stimulation (TMS)
Transcutaneous electrical nerve stimulation (TENS)
Occipital nerve stimulation
Sphenopalatine ganglion stimulation
Research Methods
Electrophysiology
Extracellular recordings
Whole-cell patch clamp
In vivo animal studies
Human intraoperative mapping
Molecular Biology
Gene expression studies
Receptor localization
Ion channel characterization
Neurotransmitter analysis
Behavioral Testing
Orofacial pain models
Trigeminal neuropathic pain
Migraine models
Allodynia assessment
Background The study of Spinal Nucleus Of Trigeminus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[American Headache Society](https://americanheadachesociety.org/)
[International Headache Society](https://ihs-headache.org/)
[Trigeminal Neuralgia Foundation](https://www.tnnme.org/)
Show full description